Goldman Sachs tops 5% stake in Nexans, holds 5.51% voting rights

غولدمان ساكس إنك
NEXUS BIOPHARMA INC

Goldman Sachs Group, Inc.

GS

0.00

NEXUS BIOPHARMA INC

NEXS

0.00

  • Goldman Sachs Group crossed above the 5% threshold in Nexans on May 21, holding 2,412,304 shares, or 5.51% of capital and voting rights.
  • The move followed an off-market share purchase.
  • Position includes 420,578 shares via a stock loan with recall rights, plus a physically settled call option on 35,000 shares at EUR 140.
  • Holding also includes 714,280 shares via cash-settled derivatives, mainly swaps, plus a small call warrant position.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nexans SA published the original content used to generate this news brief on May 29, 2026, and is solely responsible for the information contained therein.